posted 03-02-2003 07:27 PM
For a specific prostate cancer case(this spectrum may be kept wider as "cancer" as well), which way is better to check the sample of the patient against the genomic/proteomic data? (to detect whether he has cancer):1. Genomic microarray
2. Proteomic microarray
3. Instead of getting the genomic/proteomic data as the comparison value in a spesific microarray, to use the dynamic datasets in internet and to get the genetic data of the patient to make cross check between patient's data and datasets in net.
4. Out of microarrays what can be a better alternative?
5. Among microarrays which type of data included is better?
Everything you can say will be very valuable..
Thanks..